Susan Galbraith

Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

Susan Galbraith, Martin A. Lodge, N. Jane Taylor et al. · NMR in Biomedicine · 2002 · 339 citations · Full text

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging

Susan Galbraith, Ross J. Maxwell, Martin A. Lodge et al. · Journal of Clinical Oncology · 2003 · 325 citations

Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results

Gordon Rustin, Susan Galbraith, Helén Anderson et al. · Journal of Clinical Oncology · 2003 · 307 citations

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · Oxford University Research Archive (ORA) (University of Oxford) · 2002 · 231 citations

Endothelial Cell Morphology, Chemoprevention Strategy, Tumor Biology +17

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

David M. Berman, Susan Parker, Jonathan Siegel et al. · PubMed · 2010 · 227 citations · Full text

Ipilimumab Leads, Immunology, Gastroenterology +22